Generic Portal

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

de Jonge, A. V., van Werkhoven, E., Dinmohamed, A. G., Nijland, M., Zwinderman, A. H., Bossuyt, P. M., Veldhuis, M. S., Rutten, E. G. G. M., Mous, R., Vermaat, J. S. P., Sandberg, Y., de Jongh, E., Bilgin, Y. M., Boersma, R., Koene, H., Kersten, M. J., de Jong, D. & Chamuleau, M. E. D., 1 Dec 2023, In: Blood cancer journal. 13, 1, 85.

Research output: Contribution to journal › Article › Academic › peer-review

Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade

Cloherty, A. P. M., Rader, A. G., Patel, K. S., Pérez-Vargas, J., Thompson, C. A. H., Ennis, S., Niikura, M., Wildenberg, M. E., Muncan, V., Schreurs, R. R. C. E., Jean, F. & Ribeiro, C. M. S., 1 Dec 2023, In: Emerging microbes & infections. 12, 1, p. 2195020 2195020.

Research output: Contribution to journal › Article › Academic › peer-review

Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) (Trials, (2022), 23, 1, (913), 10.1186/s13063-022-06829-1)

Dutch Pancreatic Cancer Group, 1 Dec 2023, In: Trials. 24, 1, 55.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Dutch Pancreatic Cancer Group, 1 Dec 2023, In: BMC cancer. 23, 1, 70.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

Hollis, R. L., Thomson, J. P., van Baal, J., Ilenkovan, N., Churchman, M., van de Vijver, K., Dijk, F., Meynert, A. M., Bartos, C., Rye, T., Croy, I., Diana, P., van Gent, M., Creedon, H., Nirsimloo, R., Lok, C., Gourley, C. & Herrington, C. S., 1 Dec 2023, In: Scientific reports. 13, 1, 7681.

Research output: Contribution to journal › Article › Academic › peer-review

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Geurts, B. S., Battaglia, T. W., van Berge Henegouwen, J. M., Zeverijn, L. J., de Wit, G. F., Hoes, L. R., van der Wijngaart, H., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Opdam, F. L., de Jonge, M. J. A., Cirkel, G. A., Labots, M., Hoeben, A., Kerver, E. D., Bins, A. D., Erdkamp, F. G. L., van Rooijen, J. M., & 6 othersHoutsma, D., Hendriks, M. P., de Groot, J-W. B., Verheul, H. M. W., Gelderblom, H. & Voest, E. E., 1 Dec 2023, In: BMC cancer. 23, 1, 205.

Research output: Contribution to journal › Article › Academic › peer-review

Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies

Favaro, F., Both, D., Derks, I. A. M., Spaargaren, M., Muñoz-Pinedo, C. & Eldering, E., 1 Dec 2023, In: Oncogenesis. 12, 1, 6.

Research output: Contribution to journal › Article › Academic › peer-review

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

Civil, Y. A., Oei, A. L., Duvivier, K. M., Bijker, N., Meijnen, P., Donkers, L., Verheijen, S., van Kesteren, Z., Palacios, M. A., Schijf, L. J., Barbé, E., Konings, I. R. H. M., van der Houven van Oordt, C. W. M., Westhoff, P. G., Meijer, H. J. M., Diepenhorst, G. M. P., Thijssen, V., Mouliere, F., Slotman, B. J., van der Velde, S., & 1 othersvan den Bongard, H. J. G. D., 1 Dec 2023, In: BMC cancer. 23, 1, 419.

Research output: Contribution to journal › Article › Academic › peer-review

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

van Dam, K. P. J., Volkers, A. G., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Kempen, Z. L. E., Killestein, J., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Takkenberg, R. B., D’Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., Hilhorst, M. L., & 38 othersVegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Sanchez, A. P., van Els, C. C. A. C. M., de Wit, J., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, R. C. F., Teng, Y. K. O., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., van Ham, S. M., Rispens, T., on behalf of the T2B! Immunity against SARS-CoV-2 study group, Kuijpers, T. W., Löwenberg, M. & Eftimov, F., 1 Dec 2023, In: BMC infectious diseases. 23, 1, 332.

Research output: Contribution to journal › Article › Academic › peer-review

Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer

Buikhuisen, J. Y., Gomez Barila, P. M., Cameron, K., Suijkerbuijk, S. J. E., Lieftink, C., di Franco, S., Krotenberg Garcia, A., Uceda Castro, R., Lenos, K. J., Nijman, L. E., Torang, A., Longobardi, C., de Jong, J. H., Dekker, D., Stassi, G., Vermeulen, L., Beijersbergen, R. L., van Rheenen, J., Huveneers, S. & Medema, J. P., 1 Dec 2023, In: Journal of experimental & clinical cancer research. 42, 1, 56.

Research output: Contribution to journal › Article › Academic › peer-review